raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:702

Pelizaeus-Merzbacher disease

Synonyms: Diffuse familial brain sclerosis · PMD · Pelizaeus-Merzbacher brain sclerosis · Sudanophilic leukodystrophy, Paelizeus-Merzbacher type

Type
Disease
Group
Disorder
Inheritance
X-linked dominant, X-linked recessive
Age of onset
All ages
Status
active

Pelizaeus-Merzbacher disease (PMD) is an X-linked leukodystrophy characterized by developmental delay, nystagmus, hypotonia, spasticity, and variable intellectual deficit. It is classified into three sub-forms based on the age of onset and severity: connatal, transitional, and classic PMD.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPelizaeus-Merzbacher diseaseDiffuse familial brain sclerosis · PMD · Pelizaeus-Merzbacher brain sclerosis · Sudanophilic leukodystrophy, Paelizeus-Merzbacher type
frMaladie de Pelizaeus-MerzbacherLeucodystrophie sudanophile de Pelizaeus-Merzbacher · Sclérose cérébrale de Pelizaeus-Merzbacher · Sclérose cérébrale diffuse familiale
dePelizaeus-Merzbacher-KrankheitHirnsklerose, diffuse familiäre · Leukodystrophie, sudanophile, Typ Pelizeus-Merzbacher · Pelizaeus-Merzbacher Hirnsklerose
esEnfermedad de Pelizaeus-Merzbacher
itMalattia di Pelizaeus-Merzbacher
nlZiekte van Pelizaeus-MerzbacherDiffuse familiale hersensclerose · Hersensclerose van Pelizaeus-Merzbacher · PMD · Sudanofiele leukodystrofie, Paelizeus-Merzbacher-type
ptDisease Pelizaeus-Merzbacher
plChoroba Pelizaeusa i MerzbacheraPMD
csPelizaeusova-Merzbacherova nemocDifuzní familiární skleróza mozku · PMD · Pelizaeusova-Merzbacherova skleróza mozku · Sudanofilní leukodystrodie, Pelizaeusův-Merzbacherův typ · Syndrom Pelizaeusův-Merzbacherův · Pelizaeus-Merzbacherova nemoc · Pelizaeus-Merzbacherova skleróza mozku · Sudanofilní leukodystrodie, Pelizaeus-Merzbacherův typ · Syndrom Pelizaeus-Merzbacherův
ukХвороба Пеліцеуса-МерцбахераДифузний сімейний склероз головного мозку · Склероз головного мозку Пеліцеуса-Мерцбахера · PMD · Суданофільна лейкодистрофія, тип Пеліцеуса-Мерцбахера
zh佩-梅病嗜苏丹型脑白质营养不良,Paelizeus-Merzbacher型
trPelizaeus-Merzbacher hastalığıPMD · Yaygın ailesel beyin sklerozu · Pelizaeus-Merzbacher beyin sklerozu · Sudanofilik lökodistrofi, Paelizeus-Merzbacher tipi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM213900BTNTvalidated
OMIM312080Evalidated
ICD-10E75.2NTBTindexvalidated
ICD-118A44.0Especificvalidated
MONDO0010714Evalidated
MeSHD020371Evalidated
UMLSC0205711Evalidated
GARD4265Evalidated
MedDRA10067610Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (7):

Children (5):

Codes that Orphanet moved or referred to this one:

4

Genes

0 direct · 5 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PLP1ORPHA:280210Pelizaeus-Merzbacher disease, connatal formDisease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
PLP1ORPHA:280219Pelizaeus-Merzbacher disease, classic formDisease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
PLP1ORPHA:280224Pelizaeus-Merzbacher disease, transitional formDisease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
PLP1ORPHA:280229Pelizaeus-Merzbacher disease in female carriersDisease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
PLP1ORPHA:280234Null syndromeDisease-causing germline mutation(s) inAssessedHGNC:9086ENSG00000123560300401Xq22.2proteolipid protein 120301361[PMID]
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 1 000 0000.25 / 100 000EuropeValue and classValidated[EXPERT]
Point prevalence1-9 / 1 000 0000.35 / 100 000United StatesValue and classNot yet validated20301361[PMID]_ORPHANET
Prevalence at birth1-9 / 1 000 0000.13 / 100 000GermanyValue and classValidated9286459[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

32 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100022Abnormality of movement
HP:0001251Ataxia
HP:0000708Atypical behavior
HP:0004326Cachexia
HP:0002120Cerebral cortical atrophy
HP:0002376Developmental regression
HP:0001531Failure to thrive in infancy
HP:0001288Gait disturbance
HP:0001252Hypotonia
HP:0001387Joint stiffness
HP:0002808Kyphosis
HP:0000639Nystagmus
HP:0000648Optic atrophy
HP:0001622Premature birth
HP:0002650Scoliosis
HP:0001257Spasticity
HP:0000505Visual impairment
Frequent (79-30%)
HP:0002167Abnormality of speech or vocalization
HP:0000079Abnormality of the urinary system
HP:0000649Abnormality of visual evoked potentials
HP:0100026Arteriovenous malformation
HP:0002607Bowel incontinence
HP:0001266Choreoathetosis
HP:0001332Dystonia
HP:0000365Hearing impairment
HP:0001249Intellectual disability
HP:0000252Microcephaly
HP:0002205Recurrent respiratory infections
HP:0002093Respiratory insufficiency
HP:0001250Seizure
HP:0004322Short stature
Occasional (29-5%)
HP:0009830Peripheral neuropathy

Run the differential on the 12 obligate / very frequent terms

7

Sources for this card